MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
9.98
+0.87
+9.55%
After Hours: 9.98 0 0.00% 16:10 12/18 EST
OPEN
9.25
PREV CLOSE
9.11
HIGH
10.31
LOW
9.21
VOLUME
85.34K
TURNOVER
--
52 WEEK HIGH
21.00
52 WEEK LOW
2.860
MARKET CAP
107.11M
P/E (TTM)
-0.8040
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2d ago
Weekly Report: what happened at KZIA last week (1208-1212)?
Weekly Report · 3d ago
Market Pulse: Tilray Leads After-Hours Rally As Biotech Peers Surge
NASDAQ · 4d ago
Chevron To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 6d ago
Kazia Therapeutics Price Target Raised to $18.00/Share From $13.00 by HC Wainwright & Co.
Dow Jones · 6d ago
Kazia Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6d ago
HC Wainwright & Co. Maintains Buy on Kazia Therapeutics, Raises Price Target to $18
Benzinga · 6d ago
Kazia Therapeutics price target raised to $18 from $13 at H.C. Wainwright
TipRanks · 6d ago
More
About KZIA
Kazia Therapeutics Limited is an Australia-based pharmaceutical drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.